MAGENTA CLINICAL TRIAL Trademark

Trademark Overview


On Tuesday, December 10, 2024, a trademark application was filed for MAGENTA CLINICAL TRIAL with the United States Patent and Trademark Office. The USPTO has given the MAGENTA CLINICAL TRIAL trademark a serial number of 98895084. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 16, 2025. This trademark is owned by IGC Pharma IP, LLC. The MAGENTA CLINICAL TRIAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials for others; Scientific research for medical purposes in the field of CNS (central nervous system) diseases
magenta clinical trial

General Information


Serial Number98895084
Word MarkMAGENTA CLINICAL TRIAL
Filing DateTuesday, December 10, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 16, 2025

Trademark Statements


Description of MarkThe mark consists of the literal elements "MAGENTA CLINICAL TRIAL" where "MAGENTA" appears in a stylized, purple font above "CLINICAL TRIAL" which appears in a stylized, dark purple font. All of the literal elements appear to the right of a purple circle containing two dark purple rectangles and one purple rectangle. The color white represents background and is not part of the mark.
Indication of Colors claimedThe color(s) purple and dark purple is/are claimed as a feature of the mark.
NOT AVAILABLE"CLINICAL TRIAL"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; Scientific research for medical purposes in the field of CNS (central nervous system) diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 10, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIGC Pharma IP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPotomac, MD 20854

Party NameIGC Pharma IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPotomac, MD 20854

Trademark Events


Event DateEvent Description
Tuesday, December 10, 2024NEW APPLICATION ENTERED
Tuesday, May 20, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 20, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 29, 2025ASSIGNED TO EXAMINER
Wednesday, June 11, 2025NON-FINAL ACTION WRITTEN
Wednesday, June 11, 2025NON-FINAL ACTION E-MAILED
Wednesday, June 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED